← Back to Search

Quality-of-Life Assessment for Breast Cancer

Phase 1
Waitlist Available
Led By Daniela L Stan, M.D.
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Study Summary

This trial is testing a mobile app to help patients with breast cancer manage their symptoms and recovery. The app provides education materials and allows patients to contact their care team with concerns. The app may help alleviate symptoms and improve quality of life.

Eligible Conditions
  • Breast Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Symptoms assessment response rate
Secondary outcome measures
Change in patient behavior (activity)
Change in quality of life (QOL)
Change in toxicity symptom burden
+1 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Supportive care (ICP)Experimental Treatment3 Interventions
Patients complete surveys for 4 common symptoms: fatigue, hot flashes, insomnia, and sexual dysfunction and receive educational material via mobile app to help with bothersome symptoms. Patients also complete questionnaires.

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,176 Previous Clinical Trials
3,757,951 Total Patients Enrolled
83 Trials studying Breast Cancer
14,036 Patients Enrolled for Breast Cancer
National Cancer Institute (NCI)NIH
13,611 Previous Clinical Trials
40,915,914 Total Patients Enrolled
939 Trials studying Breast Cancer
1,543,333 Patients Enrolled for Breast Cancer
Daniela L Stan, M.D.Principal InvestigatorMayo Clinic in Rochester

Media Library

Interactive Care Plan Clinical Trial Eligibility Overview. Trial Name: NCT04693338 — Phase 1
Breast Cancer Research Study Groups: Supportive care (ICP)
Breast Cancer Clinical Trial 2023: Interactive Care Plan Highlights & Side Effects. Trial Name: NCT04693338 — Phase 1
Interactive Care Plan 2023 Treatment Timeline for Medical Study. Trial Name: NCT04693338 — Phase 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are involved in the clinical trial?

"Affirmative. Clinicaltrials.gov verifies that this medical investigation, which began recruiting on August 20th 2020, is currently searching for volunteers. A total of 125 participants need to be acquired from a single site."

Answered by AI

Is recruitment open for this clinical trial?

"The clinical trial is actively seeking participants. The initial posting of the study was on August 20th 2020 and it has recently been modified on May 6th 2022, as noted by clinicaltrials.gov."

Answered by AI

What kind of security measures are taken to ensure that Supportive Care is safe for individuals?

"Because of a lack of clinical data, Supportive Care was given the lowest possible safety score on our 1 to 3 rating scale. This indicates that it is still in its initial phase and more research needs to be conducted for it to become viable."

Answered by AI
~22 spots leftby Mar 2025